cupric sulfide has been researched along with Malignant Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Y; Jiao, X; Wen, Y; Yuan, Z; Zhang, K; Zhang, P; Zhang, X; Zhang, Y | 1 |
| Carrier, A; Chen, Y; Cui, S; Jiang, R; Oakes, K; Servos, M; Singh, P; Yang, Y; Youden, B; Zhang, X | 1 |
2 other study(ies) available for cupric sulfide and Malignant Melanoma
| Article | Year |
|---|---|
A controllable local drug delivery system based on porous fibers for synergistic treatment of melanoma and promoting wound healing.
Topics: Animals; Cell Adhesion; Cell Line; Cell Proliferation; Cell Survival; Copper; Disease Models, Animal; Doxycycline; Drug Delivery Systems; Female; Melanoma; Membranes, Artificial; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Photochemotherapy; Porosity; Wound Healing; Xenograft Model Antitumor Assays | 2019 |
Synergistic Multimodal Cancer Therapy Using Glucose Oxidase@CuS Nanocomposites.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Combined Modality Therapy; Copper; Drug Therapy; Enzymes, Immobilized; Glucose; Glucose Oxidase; Humans; Light; Male; Melanoma; Mice, Inbred BALB C; Mice, Nude; Nanocomposites; Photothermal Therapy | 2021 |